INS and type 2 diabetes mellitus: In experimental animals, it has been demonstrated that insulin inhibits cardioprotection afforded by ischaemic preconditioning [9] while in patients with type 2 diabetes, concerns about negative cardiac events when insulin is used as a therapeutic have been raised [10].